Received grant in 2018
As a part of the project IMPROVE, patients having undergone surgical tumor removal in the bowel are having their blood samples analysed to locate the existence of possible circulating tumor DNA. If tumor DNA is found, the risk of the disease returning can be very high.
The aim of IMPROVE-Intervention Trial is to examine if it is possible to prevent relapse of the disease by offering preventing chemotherapy.
Multidisciplinary organisation
DCCG – Danish Colorectal Cancer Group
Bio- and Genome Bank Denmark
Project stakeholders
- Karen-Lise Garm Spindler, Department of Cancer, Aarhus University Hospital. Primary contact, mail: K.G.Spindler@rm.dk
- Søren Laurberg, Department of Surgical Gastroenterology, Aarhus University Hospital
- Claus Lindbjerg Andersen, Department of Molecular Medicine (MOMA), Aarhus University Hospital